Skip to main content

Home/ healthcare regulation and scandals/ Group items tagged scientific

Rss Feed Group items tagged

pepgra

Nuances of Scientific Medical Writing - 0 views

  •  
    Scientific medical writing involves writing detailed information about the basic medical sciences, drugs and latest technological innovation in the field of medicine for a range of audiences including medical specialists and health care professionals. This scientific information is written for publication in the medical journals, medical news, and regulatory documents. Contact us at : IND:+91 8754446690 US:+1-972-502-9262 UK:+44-1143520021 info@pepgra.com www.pepgra.com
pepgra

Importance of Systematic literature search - Pepgra - 0 views

  •  
    A leading Clinical Research Organization for healthcare communication firm with years of excellence serving clients with a dedicated team of Medical, Regulatory and Scientific writers specialized in all therapeutic areas. Our Services: Regulatory Writing for Clinical trials Scientific Writing Services Medical Editing Services Publication support services Clinical Bio-Statistics Contact us at : UK: +44-1143520021 US/Canada: +1-972-502-9262 India: +91-8754446690 info@pepgra.com www.pepgra.com
Brett Snodgrass

The Breast Cancer Charity Scam - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Scandal as cheap breast cancer prevention drug is 'left on the shelf' by NHS | UK | New... - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Risk of breast cancer among young women: relationship to induced abortion. - PubMed - NCBI - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report - NEJM - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Reform, Regulation, and Pharmaceuticals - The Kefauver-Harris Amendments at 50 - NEJM - 0 views

  • Kefauver–Harris Amendments
  • thalidomide scandal
  • state
  • ...12 more annotations...
  • 17 months of hearings
  • pharmaceutical executives
  • openly berated
  • profiteering
  • doctors were portrayed as dupes of pharmaceutical companies' marketing departments
  • FDA review claims of efficacy before drug approval
  • readable generic names
  • regulation of efficacy
  • American Medical Association
  • efficacy provision
  • (Frances Kelsey),
  • thalidomide
  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer - NEJM - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

ABIM Cheating Scandal: Take a Look at Some Test Questions - Health Blog - WSJ - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

reAGENRTS_2_Ar2_Img1_03_9d59be68e2.jpg (894×600) - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

ABIM Cheating Scandal: Take a Look at Some Test Questions - Health Blog - WSJ - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

ABIM Cheating Scandal: Take a Look at Some Test Questions - Health Blog - WSJ - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

JAMA Network | JAMA | Mishandling Misconduct: The NSABP Lumpectomy Trial - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

in-Training Medical Education (#MedEd) Forum * Medstro - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Risk factors for triple-negative breast cancer in women under the age of 45 years. - Pu... - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Rapid Progression of Basal-Type Breast Cancer - NEJM - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Dr Social - Breast Cancer Fiasco Maybe only for ER PR - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Comparing Assays for Estrogen and Progesterone Receptors: Materials and Methods - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Comparing Assays for Estrogen and Progesterone Receptors: Results - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

H&R Block®-2013 Unallowed Expenses and Losses - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
1 - 20 of 24 Next ›
Showing 20 items per page